Bennett, Coleman and Co (BCCL) has acquired 6.25% stake in ICRI Research Private (IRL), a leading clinical research education company in India, a BCCL release said.
IRL Group chairman Shiv Raman Dugal said: “The market for clinical research education is growing and our association with BCCL has come at the right time and could prove to be an important milestone in the life of the company.”
India contributes only 0.7% to the total global clinical trials market of $26 billion and analysts expect India to contribute 30% of revenue by 2010. India is fast emerging as a destination for clinical trials as it provides diverse genetic pool and low-cost technical services, the release added.
ICRI society, the clinical research division of the group, is a pioneer of clinical research education in India and is growing at over 100% annually. Currently, ICRI has four campuses in Delhi, Mumbai, Bangalore and Ahmedabad. It is also exploring setting up campuses abroad and has a tie-up with Cranefield University (UK) for research & faculty support.
(Source: Economic Times)
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment